Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Cash & Equivalents (2016 - 2025)

Eastman Chemical (EMN) has disclosed Cash & Equivalents for 17 consecutive years, with $566.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 32.38% year-over-year to $566.0 million, compared with a TTM value of $566.0 million through Dec 2025, down 32.38%, and an annual FY2025 reading of $566.0 million, down 32.38% over the prior year.
  • Cash & Equivalents was $566.0 million for Q4 2025 at Eastman Chemical, up from $489.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $837.0 million in Q4 2024 and bottomed at $410.0 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $529.3 million, with a median of $496.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 35.7% in 2022, then soared 52.74% in 2024.
  • Year by year, Cash & Equivalents stood at $459.0 million in 2021, then increased by 7.41% to $493.0 million in 2022, then grew by 11.16% to $548.0 million in 2023, then surged by 52.74% to $837.0 million in 2024, then plummeted by 32.38% to $566.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for EMN at $566.0 million in Q4 2025, $489.0 million in Q3 2025, and $423.0 million in Q2 2025.